In the recent model by Gerber et al. discussed in “Stiff Skin Syndrome,” knock-in human fibrillin-1 mutations were introduced and the mice demonstrated a phenotype that included dermal fibrosis, inflammation, and autoimmunity. This evidence concerns the gene FBN1 and stiff skin syndrome.